Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
Xiaoju Zhou,1,2,* Mengzi Zhang,2,* Bryant Yung,2 Hong Li,2 Chenguang Zhou,2 L James Lee,3,4 Robert J Lee2,41State Key Laboratory of Virology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Wuhan University School of Pharmaceutical Sciences, Wuhan, People&a...
Guardado en:
Autores principales: | Zhou X, Zhang M, Yung B, Li H, Zhou C, Lee LJ, Lee RJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b01fc40554ad48549e12d2312bb67efa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
por: Wei MY, et al.
Publicado: (2015) -
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
por: Zhang W, et al.
Publicado: (2015) -
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
por: Xue H, et al.
Publicado: (2019) -
Mannosylated liposomes for targeted gene delivery
por: Kong F, et al.
Publicado: (2012) -
Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma
por: Xue H, et al.
Publicado: (2017)